A Review of Quercetin: Anti-Cancer Activity

Year 2020, Volume: 4 Issue: 1, 1 - 7, 15.07.2020

Vijay Kumar Panthı Sharmila Kaushal Bishnu Adhıkarı Nawaraj Basnet Dharmendra Chaudhary Rishi Ram Pajarulı Priyanka Pokhrel

Abstract

Quercetin is the principal flavonoid compound commonly extracted from cranberries, blueberries, apples and onions. It possesses a wide spectrum of bio-pharmacological properties and may offer promising new options for the development of more effective chemo-preventive and chemo-therapeutic strategies owing to its powerful antioxidant and free-radical scavenging properties. Several studies demonstrated that quercetin has a significant role in inhibition of tumor and cancer cells on breast, colon, prostate, ovary, endometrium, and lung. Quercetin treatment has been associated with selective anti-proliferative effects and induction of cell death, probably through an apoptotic mechanism, in breast or other cancer cell lines but not in normal cells. Quercetin is universally known for its low toxicity as a natural product despite the limited information on dosing regimens. The major problem associated with the use of quercetin, is the very low bioavailability. Beside cancer chemotherapy, it also exhibits various pharmacological actions including: antiviral, antioxidant, anticancer, antimicrobial, anti-inflammatory, neurological effects, cardiovascular, and hepatoprotective. Quercetin has been reported as a potent anticancer agent during in vitro studies on various cancer cell lines and in vivo studies on rodents especially mice. Quercetin has radical scavenging potential, therefore, it is capable of preventing cancer induced by oxidative stress. The chemo-protective action of quercetin through apoptosis and metastasis against tumor cell lines makes it a strong candidate as a potential anticancer agent.

Keywords

Anticancer activity, bioavailability, safety, quercetin

References

• Xiao ZP, Peng ZY, Peng MJ, Yan WB, Ouyang YZ, Zhu HL. Flavonoids health benefits and their molecular mechanism. Mini Reviews in Medicinal Chemistry (2011) 11(2):169–177.
• Haddad AQ, Fleshner N, Nelson C, Saour B, Musquera M, Venkateswaran V, et al. Antiproliferative mechanisms of the flavonoids 2,21-dihydroxychalcone and fisetin in human prostate cancer cells. Nutrition and Cancer (2010) 62(5):668–681.
• Rodgers EH, Grant MH. The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. Chemico-biological Interactions (1998) 116(3):213–228.
• Liesveld JL, Abboud CN, Lu C, McNair C, Menon A, Smith A, et al. Flavonoid effects on normal and leukemic cells. Leukemia Research (2003) 27(6):517–527. doi:10.1016/S0145-2126(02)00265-5.
• Richter M, Ebermann R, Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutrition and Cancer (1999) 34(1):88–99.
• Bhise SB, Nalawade AD, Wadhawa H. Role of protein tyrosine kinase inhibitors in cancer therapeutics. Indian Journal of Biochemistry and Biophysics (2004) 41(6):273–280.
• Srivastava AK. Inhibition of phosphorylase kinase, and tyrosine protein kinase activities by quercetin. Biochemical and Biophysical Research Communications (1985) 131(1):1–5.
• Formica JV, Regelson W. Review of the biology of Quercetin and related bioflavonoids. Food and Chemical Toxicology (1995) 33(12):1061–1080.
• Bors W, Michel C, Saran M. Flavonoid antioxidants: Rate constants for reactions with oxygen radicals. Methods in Enzymology (1994) 234:420–429.
• Prior RL. Fruits and vegetables in the prevention of cellular oxidative damage. The American Journal of Clinical Nutrition (2003) 78(3 Suppl):570–578.
• Erkoç Ş, Erkoç F, Keskin N. Theoretical investigation of quercetin and its radical isomers. Journal of Molecular Structure: THEOCHEM (2003) 631(1-3):141–146.
• Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C, et al. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutrition and Cancer (2000) 37(2):223–233.
• Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition (2005) 81(1-Suppl):230–242.
• Dajas F. Life or death: Neuroprotective and anticancer effects of quercetin. Journal of Ethnopharmacology (2012) 143(2):383–396.
• Ferry DR, Smith A, Malkhandi J, Fyfe DW, Detakats PG, Anderson D, et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clinical Cancer Research (1996) 2(4):659–668.
• Jan AT, Kamli MR, Murtaza I, Singh JB, Ali A, Haq QMR. Dietary Flavonoid Quercetin and Associated Health Benefits An Overview. Food Reviews International (2010) 26(3):302–317.
• Seufi AEM, Ibrahim SS, Elmaghraby TK, Hafez EE. Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. Journal of Experimental and Clinical Cancer Research (2009) 28(1):1–8.
• Su-Ni T, Chandan S, Dara N, Daniel M, Sharmila S, Rakesh KS. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. Journal of Molecular Signaling (2010) 5(14):1–15.
• Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C. Plasma metabolites of quercetin and their antioxidant properties. The American Journal Physiology (1998) 275(1):212–219.
• Cornard JP, Dangleterre L, Lapouge C. Computational and spectroscopic characterization of the molecular and electronic structure of the Pb (II)-quercetin complex. The Journal of Physical Chemistry A (2005) 109(44):10044–10051.
• Mendoza-Wilson AMA, Glossman-Mitnik D. CHIH-DFT determination of the molecular structure, infrared and ultraviolet spectra of the flavonoid quercetin. Journal of Molecular Structure: THEOCHEM (2007) 681(1-3):71–76.
• Maalik A, Khan FA, Mumtaz A, Mehmood A. Pharmacological Applications of Quercetin and its Derivatives. Tropical Journal of Pharmaceutical Research (2014) 13(9):1561–1566.
• Fischer C, Speth V, Fleig-Eberenz S, Neuhaus G. Induction of zygotic polyembryos in wheat: Influence of auxin polar transport. Plant Cell (1997) 9(10):1767–1780.
• Williams CA, Grayer RJ. Anthocyanins and other flavonoids. Natural Product Reports (2004) 21(4):539–573.
• Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry (2000) 55(6):481–504.
• Fang N, Yu S, Mabry TJ. Flavonoids from Ageratina calophylla. Phytochemistry (1986) 25(11):2684–2686.
• Zeng LM, Wang CJ, Su JY, Li D, Owen NL, Lu Y, et al. Flavonoids from the red alga Acanthophora spicifera. Chinese Journal of Chemistry (2001) 19(11):1097–1100.
• Dal Santo S, Tornielli GB, Zenoni S, Fasoli M, Farina L, Anesi A, et al. The plasticity of the grapevine berry transcriptome. Genome Biology (2013) 14(6):r54.
• Rice-Evans C, Miller N, Paganga G. Antioxidant properties of phenolic compounds. Trends in Plant Science (1997) 2(4):152–159.
• Murota K, Shimizu S, Miyamoto S, Izumi T, Obata A, Kikuchi M, et al. Unique uptake and transport of isoflavone aglycones by human intestinal Caco-2 cells: Comparison of isoflavonoids and flavonoids. Journal of Nutrition (2002) 132(7):1956–1961.
• Terao J, Kawai Y, Murota K. Vegetable flavonoids and cardiovascular disease. Asia Pacific Journal of Clinical Nutrition (2008) 17(1 Suppl):291–293.
• Moon JH, Nakata R, Oshima S, Inakuma T, Terao J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (2000) 279(2):461–467.
• Shimoi K, Saka N, Nozawa R, Sato M, Amano I, Nakayama T, et al. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metabolism and Disposition (2001) 29(12):1521–1524.
• Boer V de, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, et al. Tissue distribution of quercetin in rats and pigs. Journal of Nutrition (2005) 135(7):1718–1725.
• Kawai Y, Nishikawa T, Shiba Y, Saito S, Murota K, Shibata N, et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries implication in the anti-atherosclerotic mechanism of dietary flavonoids. Journal of Biological Chemistry (2008) 283(14):9424–9434.
• Lamson DW, Brignall MS. Antioxidants and cancer, part 3: quercetin. Alternative medicine review a journal of clinical therapeutic (2000) 5(3):196–208.
• Boots AW, Haenen GR, G.J H, Bast A. Oxidative damage shifts from lipid peroxidation to thiolarylation by catechol-containing antioxidants. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2002) 1583(3):279–284.
• Bindoli A, Valente M, Cavallini L. Inhibitory action of quercetin on xanthine oxidase and xanthine dehydrogenase activity. Pharmacological Research Communications (1985) 17(9):831–839.
• Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H, et al. IFN-γ induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. Journal of Immunology (2003) 170(7):3890–3897.
• Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. Journal of Experimental Medicine (2000) 192(4):565–570.
• Degryse B, Bonaldi T, Scaffidi P, Müller S, Resnati M, Sanvito F, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Journal of Cell Biology (2001) 152(6):1197–1206.
• Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. Journal of Biological Chemistry (2004) 279(9):7370–7377.
• Kokkola R, Andersson A, Mullins G, Östberg T, Treutiger CJ, Arnold B, et al. RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages. Scandinavian Journal of Immunology (2005) 61(1):1–9.
• Luo JL, Kamata H, Karin M. IKK/NF-κB signaling: Balancing life and death—A new approach to cancer therapy. Journal of Clinical Investigation (2005) 115(10):2625–2632.
• Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. Journal of Experimental Medicine (2009) 206(5):1135–1147.
• Wilson, SR, The L, Batia LM, Beattie K, Katibah GE, McClain SP, Pellegrino M, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell (2013) 155(2):285–295.
• Zhong J, Sharma J, Raju R, Palapetta SM, Prasad TK, Huang TC, et al. TSLP signaling pathway map: A platform for analysis of TSLP-mediated signaling. The Journal of Biological Databases and Curation (2014):bau007. doi:10.1093/database/bau007.
• Arima K, Watanabe N, Hanabuchi S, Chang M, Sun SC, Liu YJ. Distinct signal codes generate dendritic cell functional plasticity. Science Signaling (2010) 3(105):ra4.
• Bao L, Zhang H, Chan LS. The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis. JAK-STAT (2013) 2(3):e24137-1.
• Horr B, Borck H, Thurmond R, Grösch S, Diel F. STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes. International Immunopharmacology (2006) 6(10):1577–1585.
• Muthian G, Bright JJ. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. Journal of Clinical Immunology (2004) 24:542–552.
• Liao YR, Lin JY. Quercetin, but not its metabolite quercetin-3-glucuronide, exerts prophylactic immunostimulatory activity and therapeutic antiinflammatory effects on lipopolysaccharide-treated mouse peritoneal macrophages ex vivo. Journal of Agricultural and Food Chemistry (2014) 62(13):2872–2880.
• Senggunprai L, Kukongviriyapan V, Prawan A, Kukongviriyapan U. Quercetin and EGCG exhibit chemo preventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway. Phytotherapy Research (2014) 28(6):841–848.
• Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators of Inflammation (2007) 2007:45673.
• Baghel SS, Shrivastava N, Baghel RS, Agrawal P, Rajput S. A review of quercetin: antioxidant and anticancer properties. Journal of Pharmacy and Pharmaceutical Sciences (2012) 1(1):146–160.
• Gibellini L, Pinti M, Nasi M, Montagna JP, Biasi S de, Roat E, et al. Quercetin and Cancer Chemoprevention. Evidence-based complementary and alternative medicine eCAM (2011) 2011:591356. doi:10.1093/ecam/neq053.
• Du G, Lin H, Yang Y, Zhang S, Wu X, Wang M, et al. Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. International Immunopharmacology (2010) 10(7):819–826.
• Oh SJ, Kim O, Lee JS, Kim JA, Kim MR, Choi HS, et al. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells. Food and Chemical Toxicology (2010) 48(11):3227–3234.
• Han C, Heyan G, Zhang X. The anti-cancer effect of quercetin in renal cancer through regulating survivin expression and caspase 3 activity. Med One (2016) 1(1):3. doi:10.20900/mo.20160003.
• Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, et al. Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs (2006) 17(6):663–671.
• Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Letters (2008) 269(2):315–325.
• Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. International Journal of Cancer (2000) 87(4):595–600.
• Nam J-S, Sharma AR, Nguyen LT, Chakraborty C, Sharma G, Lee S-S. Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine. Molecules (2016) 21(1):E108.
• Joshi U, S.Gadge A, P MD, Sinha R, Srivastava S, Govil G. Anti-inflammatory, antioxidant and anticancer activity of Quercetin and its analogues. International Journal of Research in Pharmaceutical and Biomedical Sciences (2011) 2(4).
• Smith AJ, Oertle J, Warren D, Prato D. Quercetin: A Promising Flavonoid with a Dynamic Ability to Treat Various Diseases, Infections, and Cancers. Journal of Cancer Therapy (2016) 7(2):83–95.